Repositorio Dspace

Early oncological outcomes of delayed radical prostatectomy: A prospective, international, follow-up analysis of the COVIDSurg-Cancer study

Mostrar el registro sencillo del ítem

dc.contributor.author Nathan, Arjun
dc.contributor.author Gao, Chuanyu
dc.contributor.author Light, Alexander
dc.contributor.author Alexander, Cameron-E
dc.contributor.author Chan, Vinson
dc.contributor.author Gallagher, Kevin
dc.contributor.author Khadhouri, Sinan
dc.contributor.author Byrnes, Kevin-G
dc.contributor.author Ng, Michael
dc.contributor.author Walters, Michael
dc.contributor.author Hughes, Terry
dc.contributor.author Perry, Rita-J
dc.contributor.author Okoth, Kelvin
dc.contributor.author Magill, Laura
dc.contributor.author Pinkney, Thomas
dc.contributor.author Zhang, Yuhao
dc.contributor.author Blackmur, James
dc.contributor.author Etchill, Eric
dc.contributor.author Tang, Stanley
dc.contributor.author García-Escudero, Damián
dc.contributor.author McNeill, Alan
dc.contributor.author Narahari, Krishna
dc.contributor.author Stewart, Grant-D
dc.contributor.author Kasivisvanathan, Veeru
dc.date.accessioned 2025-11-18T09:33:55Z
dc.date.available 2025-11-18T09:33:55Z
dc.date.issued 2024
dc.identifier.citation Nathan A, Gao C, Light A, Alexander C, Chan V, Gallagher K, et al. Early oncological outcomes of delayed radical prostatectomy: A prospective, international, follow-up analysis of the COVIDSurg-Cancer study. BJUI Compass. diciembre de 2024;5(12):1314-23.
dc.identifier.issn 2688-4526
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/20889
dc.description.abstract OBJECTIVES: The objective of this study is to compare the early oncological outcomes of delayed (>90-days) versus scheduled (¿90-days) radical prostatectomy (RP). PATIENTS AND METHODS: Patients with prostate cancer due to undergo surgery between March 2020 and June 2020 who were enrolled in the COVIDSurg-Cancer international, observational study were prospectively followed up for 1 year. Time to surgery was defined as the difference between the operation date and the multi-disciplinary team decision to offer surgery. The primary outcome was the positive surgical margin (PSM) rate. Biochemical recurrence (BCR), upgradation and upstaging were secondary oncological outcomes. The Independent t-test and Mann Whitney U test were used to compare means between groups and regression models and were used to investigate factors associated with the primary outcome. RESULTS: Four hundred seventy-six (78.7%) patients underwent RP from 605 that were eligible. Three hundred seven (64.5%) patients underwent scheduled RP, and 169 (35.5%) underwent delayed RP. A small proportion of men (n =-35, 6.8%) did not undergo RP within the 1-year follow-up period. More men with high-risk disease (72.8%) underwent scheduled RP compared to men with intermediate-risk disease (60.2%) (p <-0.05). There was no statistically significant difference in the PSM rate between the two groups (p =-0.512). Delay in surgery was not associated with an increased PSM or BCR on univariable or multivariable analyses. There was statistically significantly greater upstaging (p <-0.05) in the delayed group but no difference in upgradation. CONCLUSION: High-risk men were prioritised for surgery during the COVID-19 pandemic. Our prospective data support previous retrospective, cancer-registry evidence suggesting no adverse oncological impact after delaying RP across all risk groups. Our study is limited by the short follow-up period, and therefore, longer term conclusions cannot be drawn.
dc.language.iso eng
dc.publisher John Wiley And Sons Inc
dc.subject.mesh Humans
dc.subject.mesh Blepharospasm/drug therapy
dc.subject.mesh Botulinum Toxins/adverse effects
dc.subject.mesh Hemifacial Spasm/drug therapy
dc.subject.mesh Prospective Studies
dc.subject.mesh Dystonia/drug therapy
dc.subject.mesh Anterior Chamber
dc.subject.mesh Injections, Intraocular
dc.subject.mesh Botulinum Toxins, Type A/adverse effects
dc.title Early oncological outcomes of delayed radical prostatectomy: A prospective, international, follow-up analysis of the COVIDSurg-Cancer study
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 39744074
dc.relation.publisherversion https://bjui-journals.onlinelibrary.wiley.com/doi/10.1002/bco2.433
dc.identifier.doi 10.1002/bco2.433
dc.journal.title Bjui Compass


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta